Webinar
February 27, 2025 at 2:00 PM
Online
WEbinar
February 27, 2025 at 2:00 PM
Online
Webinar
February 27, 2025 at 2:00 PM
Online
Overview
Revolutionary Psychedelics: MDMA Breakthroughs and Mental Health with Matthew Baggott
Discover how groundbreaking research is transforming the field of psychedelics and redefining possibilities in medicine. This is a unique opportunity to hear from a leading expert and gain valuable insights into the rapidly evolving world of psychedelic science.
Whether you’re a clinician, researcher, or simply curious about the future of drug development, this webinar is not to be missed!
Featuring Matthew Baggott, Lead Research Scientist and CEO of Tactogen, a pioneering company at the forefront of drug development. In this engaging session, Matthew will delve into the latest advancements in the development of MDMA and other entactogens, shedding light on their therapeutic potential, challenges in clinical trials, and future applications in mental health treatment.
This insightful session will dive into:
Current advancements in MDMA research and its therapeutic uses.
Insights into the development of entactogens and their applications.
The future of psychedelic medicine in mental health treatment.
Topic
MDMA
Entactogens
Type
Webinar
Overview
Revolutionary Psychedelics: MDMA Breakthroughs and Mental Health with Matthew Baggott
Discover how groundbreaking research is transforming the field of psychedelics and redefining possibilities in medicine. This is a unique opportunity to hear from a leading expert and gain valuable insights into the rapidly evolving world of psychedelic science.
Whether you’re a clinician, researcher, or simply curious about the future of drug development, this webinar is not to be missed!
Featuring Matthew Baggott, Lead Research Scientist and CEO of Tactogen, a pioneering company at the forefront of drug development. In this engaging session, Matthew will delve into the latest advancements in the development of MDMA and other entactogens, shedding light on their therapeutic potential, challenges in clinical trials, and future applications in mental health treatment.
This insightful session will dive into:
Current advancements in MDMA research and its therapeutic uses.
Insights into the development of entactogens and their applications.
The future of psychedelic medicine in mental health treatment.
Topic
MDMA
Entactogens
Type
Webinar
Overview
Revolutionary Psychedelics: MDMA Breakthroughs and Mental Health with Matthew Baggott
Discover how groundbreaking research is transforming the field of psychedelics and redefining possibilities in medicine. This is a unique opportunity to hear from a leading expert and gain valuable insights into the rapidly evolving world of psychedelic science.
Whether you’re a clinician, researcher, or simply curious about the future of drug development, this webinar is not to be missed!
Featuring Matthew Baggott, Lead Research Scientist and CEO of Tactogen, a pioneering company at the forefront of drug development. In this engaging session, Matthew will delve into the latest advancements in the development of MDMA and other entactogens, shedding light on their therapeutic potential, challenges in clinical trials, and future applications in mental health treatment.
This insightful session will dive into:
Current advancements in MDMA research and its therapeutic uses.
Insights into the development of entactogens and their applications.
The future of psychedelic medicine in mental health treatment.
Topic
MDMA
Entactogens
Type
Webinar
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
What students have to say about this program...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson
LCSW
I've been more than thrilled about my experience with Fluence thus far. I am a ketamine-assisted psychotherapist and
continue to learn more information and modalities to incorporate into my practice, from both the instructors and
fellow students.
LAURA HUTCHINS,
LCMHC, LCAS, KAP Consulting
My entire experience with Fluence has been exceptional. The instructors are giants in the psychedelic field, many are active in clinical research and you will see their names in scientific publications.
Stephanie Barss,
FNP, PMHNP, Psilocybin-Assisted Therapy
Certificate Program Advisor
The trainers at Fluence are what continually confirm that I am in the right place. The reverence and honor with which they approach their work is so evident. I have felt a sense of safety
at Fluence that is not present in other organizations I have
trained with or researched, and it is the trainers who create that safety.
Andrea Bigenho,
LPC specialist in Psychedelic Integration
What are students say…
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,
LCSW
What students have to say about this program...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,
LCSW
Authorized provider of continuing education.


Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.


Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.


Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.

Have questions? Ask our experts.
Have questions?
Ask our experts.
Have questions? Ask our experts.
Subscribe to our newsletter!


Professional Certificates
Subscribe to our newsletter!


Professional Certificates
Subscribe to our newsletter!


Professional Certificates